Bayer CEO Says R&D Spending May Rise Next Year

Bayer CEO Says R&D Spending May Rise Next Year Play

Oct. 30 (Bloomberg) -- Marijn Dekkers, chief executive officer of Bayer AG, discusses the company's agreement to buy Schiff Nutrition International Inc., acquisition strategy and research investments. He speaks from Leverkusen, Germany, with Manus Cranny on Bloomberg Television's "The Pulse." (Source: Bloomberg)

  • On Air Now

    Bloomberg Surveillance Watch Now

  • Next

    In The Loop with Betty Liu

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus